The Versatile Role of Alveolar Macrophages in Health and Disease

Total Page:16

File Type:pdf, Size:1020Kb

The Versatile Role of Alveolar Macrophages in Health and Disease International Journal of Molecular Sciences Review Beyond “Big Eaters”: The Versatile Role of Alveolar Macrophages in Health and Disease Miriam Hetzel 1,2, Mania Ackermann 1,2,3 and Nico Lachmann 2,3,4,5,* 1 Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany; [email protected] (M.H.); [email protected] (M.A.) 2 REBIRTH Research Center for Translational and Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany 3 Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, 30625 Hannover, Germany 4 Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), 30625 Hannover, Germany 5 Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, 30625 Hannover, Germany * Correspondence: [email protected] Abstract: Macrophages act as immune scavengers and are important cell types in the homeostasis of various tissues. Given the multiple roles of macrophages, these cells can also be found as tissue resident macrophages tightly integrated into a variety of tissues in which they fulfill crucial and organ-specific functions. The lung harbors at least two macrophage populations: interstitial and alveolar macrophages, which occupy different niches and functions. In this review, we provide the latest insights into the multiple roles of alveolar macrophages while unraveling the distinct factors which can influence the ontogeny and function of these cells. Furthermore, we will high- light pulmonary diseases, which are associated with dysfunctional macrophages, concentrating on Citation: Hetzel, M.; Ackermann, M.; congenital diseases as well as pulmonary infections and impairment of immunological pathways. Lachmann, N. Beyond “Big Eaters”: Moreover, we will provide an overview about different treatment approaches targeting macrophage The Versatile Role of Alveolar dysfunction. Improved knowledge of the role of macrophages in the onset of pulmonary diseases Macrophages in Health and Disease. may provide the basis for new pharmacological and/or cell-based immunotherapies and will extend Int. J. Mol. Sci. 2021, 22, 3308. our understanding to other macrophage-related disorders. https://doi.org/10.3390/ijms22073308 Keywords: alveolar macrophage; surfactant; pulmonary infections; asthma; fibrosis; tolerogenic po- Academic Editors: Malgorzata Kloc and Jacek Z Kubiak tential; pulmonary alveolar proteinosis; monocytes Received: 24 February 2021 Accepted: 20 March 2021 Published: 24 March 2021 1. Introduction Tissue resident macrophages (TRM) have recently been highlighted as key play- Publisher’s Note: MDPI stays neutral ers in the tissue homeostasis of various organs. Within the lung, several subsets of with regard to jurisdictional claims in macrophages exist, such as interstitial macrophages (IM) or alveolar macrophages (AM). In published maps and institutional affil- fact, nonalveolar IM are located primarily in the lung tissue around blood vessels or peri- iations. bronchial and significantly contribute to lung immune homeostasis and other tolerogenic cellular pathways. In contrast, the classical AM reside in the bronchioalveolar space and represent an important cell type in lung surfactant homeostasis, pulmonary host defense, and tissue tolerance (Figure1). In the alveolar space, AM are the best characterized and the Copyright: © 2021 by the authors. most abundant cell type and due to their crucial role direct impairment in both, function Licensee MDPI, Basel, Switzerland. and ontogeny of AM was noted to be important in the onset and progression of a variety This article is an open access article of lung diseases [1]. Of note, while IM also fulfil manifold important functions in lung distributed under the terms and homeostasis (as reviewed elsewhere [2]), we here focus on the contribution of AM to the conditions of the Creative Commons onset and progression of certain lung diseases. Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). Int. J. Mol. Sci. 2021, 22, 3308. https://doi.org/10.3390/ijms22073308 https://www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 2 of 25 stem cells (HSC). Studies in the murine system showed that erythro‐myeloid progenitors (EMP) give rise to premacrophages, which colonize the individual tissues, including the lung, before birth and give rise to TRM populations [3]. In the human system, recent in‐ sights suggest a similar developmental trajectory, which follows a spatiotemporal dy‐ namic of TRMs [4]. In the absence of inflammation and tissue damage, alveolar macro‐ phages are long lived and can self‐maintain their cell pool by local proliferation, with only minor contribution of adult monocytes over time. However, inflammatory processes can trigger the recruitment of monocytes to the lung, where they potentially participate in pathogenic processes. Under which circumstances these monocytes reside in the lungs and to which degree they finally resemble resident AMs is still under debate. In this con‐ text, the “niche model” suggests that strong triggers from the lung microenvironment im‐ Int. J. Mol. Sci. 2021, 22, 3308 print the AM phenotype on the infiltrating monocytes over time. Indeed, recent work2 by of 22 Evren and colleagues demonstrated that human monocytes are able to adopt an AM phe‐ notype over time and reside long‐term in the lung of immunodeficient mice [5]. FigureFigure 1. Impairment 1. Impairment of alveolar of alveolar macrophages macrophages leads leads to specific to specific diseases diseases or infections. or infections. Alveolar Alveolar macrophages macrophages (AM) (AM)are the are mostthe abundant most abundant cell type cell in type the inbronchioalveolar the bronchioalveolar space. space. Given Giventhe high the plasticity high plasticity of AM of and AM the and possibility the possibility to switch to switch be‐ tween different activation stages, alteration of AM can lead to a nonfunctional polarization/activation and subsequent between different activation stages, alteration of AM can lead to a nonfunctional polarization/activation and subsequent alterations in, e.g., maintaining tissue homeostasis (1). Furthermore, genetic and environmental factors can also influence alterations in, e.g., maintaining tissue homeostasis (1). Furthermore, genetic and environmental factors can also influence the antimicrobial function of AM, which can lead to life‐threatening pulmonary infections (e.g., bacterial airway infections) (2).the Dysfunction antimicrobial of AM function due ofto AM,genetic which mutations can lead or to other life-threatening factors can pulmonaryalso alter signaling infections pathways (e.g., bacterial (e.g., airwaythe CSF2 infections) path‐ way),(2). Dysfunctionwhich ultimately of AM can due lead to to genetic impaired mutations tissue homeostasis, or other factors e.g., can clearance also alter of signaling surfactant pathways material, (e.g., as seen the in CSF2 Pulmonary pathway), Alveolarwhich ultimatelyProteinosis can (3) (Created lead to impaired with BioRender.com). tissue homeostasis, e.g., clearance of surfactant material, as seen in Pulmonary Alveolar Proteinosis (3) (Created with BioRender.com). Genetic defects, environmental factors, drugs and other determinants can influence Under healthy, steady-state conditions, AM are predominantly derived from Myb- both the ontogeny and function of AM, leading to a variety of diseases. In fact, recent independent yolk sac progenitors, which develop before the emergence of hematopoietic research investigating the driving factors of patient’s susceptibility to pulmonary infec‐ stem cells (HSC). Studies in the murine system showed that erythro-myeloid progeni- tions proved that signaling pathways like GM‐CSF, or type I and/or II interferon signaling tors (EMP) give rise to premacrophages, which colonize the individual tissues, includ- can be responsible for impaired development and/or function of AM [6,7] (Figure 2). Fur‐ ing the lung, before birth and give rise to TRM populations [3]. In the human system, recent insights suggest a similar developmental trajectory, which follows a spatiotempo- ral dynamic of TRMs [4]. In the absence of inflammation and tissue damage, alveolar macrophages are long lived and can self-maintain their cell pool by local proliferation, with only minor contribution of adult monocytes over time. However, inflammatory pro- cesses can trigger the recruitment of monocytes to the lung, where they potentially par- ticipate in pathogenic processes. Under which circumstances these monocytes reside in the lungs and to which degree they finally resemble resident AMs is still under debate. In this context, the “niche model” suggests that strong triggers from the lung microenviron- ment imprint the AM phenotype on the infiltrating monocytes over time. Indeed, recent work by Evren and colleagues demonstrated that human monocytes are able to adopt an AM phenotype over time and reside long-term in the lung of immunodeficient mice [5]. Genetic defects, environmental factors, drugs and other determinants can influence both the ontogeny and function of AM, leading to a variety of diseases. In fact, recent re- search investigating the driving factors of patient’s susceptibility to pulmonary infections proved that signaling pathways like GM-CSF, or type I and/or II interferon signaling can Int. J. Mol. Sci. 2021, 22, 3308 3 of 22 Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 3 of 25 be responsible
Recommended publications
  • Supplemental Material 1 (PDF)
    Supplementary Figure 1. Murine and human GATA2 promoter alignment shows highly conserved regions. Brackets delimit the highly conserved regions in both genomes, as graphics obtained from ECR Browser show: large areas marked in red indicate highly similar intergenic sequences, repetitive sequences in green, exonic sequences in yellow, and intronic sequences in salmon color. Horizontal axis represents base positions in the genome and the vertical axis represents the percentage identity between the human and mouse genomes. GATA2 binding sites are indicated in red within the brackets, and they were located using the TFSearch, Match and MatInspector transcription factor binding site finder algorithms. Comparison of GATA2 binding sites between both genomes and several surrounding nucleotides is shown in the middle, where GATA2 binding site core sequences are shown in italic and underlined. Two GATA2 binding sites at -2.8 belonged to a highly conserved region spanning 389 bp, with 87.7% homology with the human GATA2 promoter. Similarly, other two GATA2 binding sites at -1.8 were located within a 282 bp region with 75.5% homology. Additionally, a third 142 bp region was taken into account containing the -2992 GATA2 binding site, which showed 68.3% homology. Supplementary Table I: List of reported germline GATA2 mutations and associated syndromes. Mutation (DNA)* Affected exon Mutation (protein) Mutation type Affected ZF Reference Cases/families Associated syndrome c.1-200_871+527del2033 4, 5 p.Met1_Ser290del In-frame deletion None 4,7,20,S1 2/1
    [Show full text]
  • Severe COVID-19: Understanding the Role of Immunity, Endothelium, and Coagulation in Clinical Practice
    ARTIGO DE REVISÃO ISSN 1677-7301 (Online) COVID-19 grave: entenda o papel da imunidade, do endotélio e da coagulação na prática clínica Severe COVID-19: understanding the role of immunity, endothelium, and coagulation in clinical practice Simone Cristina Soares Brandão1 , Emmanuelle Tenório Albuquerque Madruga Godoi1 , Júlia de Oliveira Xavier Ramos1 , Leila Maria Magalhães Pessoa de Melo2 , Emanuel Sávio Cavalcanti Sarinho1 Resumo O SARS-CoV-2 é o responsável pela pandemia da COVID-19. O sistema imunológico é fator determinante no combate à infecção viral e, quando atua equilibrada e eficientemente, a doença é autolimitada e benigna. Uma parcela significativa da população, porém, apresenta resposta imune exacerbada. Os indivíduos diabéticos, hipertensos, obesos e com doenças cardiovasculares, infectados pelo vírus, apresentam maior chance de progredir para formas graves. Essas doenças estão relacionadas a processos inflamatórios crônicos e disfunção endotelial. Os receptores do tipo Toll estão presentes nas células de defesa e participam da imunopatologia de doenças cardiovasculares e metabólicas, levando à produção de citocinas pró-inflamatórias quando ativados. Devido à ação viral e à hiperativação do sistema imune, estados de hiperinflamação, hiperativação plaquetária, disfunção endotelial e hipercoagulabilidade são desenvolvidos, predispondo a tromboses venosas e arteriais. Discutiremos sobre a interação entre a COVID-19, a imunidade, o endotélio e a coagulação, como também sobre as possíveis causas de doenças cardiometabólicas impactarem negativamente na evolução da COVID-19. Palavras-chave: COVID-19; endotélio; imunidade; aterosclerose; trombose. Abstract SARS-CoV-2 is responsible for the COVID-19 pandemic. The immune system is a determinant factor in defense against viral infections. Thus, when it acts in a balanced and effective manner the disease is self-limited and benign.
    [Show full text]
  • Regulation of Macrophage Development and Function in Peripheral Tissues
    REVIEWS Regulation of macrophage development and function in peripheral tissues Yonit Lavin, Arthur Mortha, Adeeb Rahman and Miriam Merad Abstract | Macrophages are immune cells of haematopoietic origin that provide crucial innate immune defence and have tissue-specific functions in the regulation and maintenance of organ homeostasis. Recent studies of macrophage ontogeny, as well as transcriptional and epigenetic identity, have started to reveal the decisive role of the tissue stroma in the regulation of macrophage function. These findings suggest that most macrophages seed the tissues during embryonic development and functionally specialize in response to cytokines and metabolites that are released by the stroma and drive the expression of unique transcription factors. In this Review, we discuss how recent insights into macrophage ontogeny and macrophage–stroma interactions contribute to our understanding of the crosstalk that shapes macrophage function and the maintenance of organ integrity. Mononuclear phagocyte Macrophages are key components of the innate immune characterized the transcriptional and epigenetic pro- system system that reside in tissues, where they function as grammes of tissue-resident macrophages and revealed (MPS). A group of bone immune sentinels. They are uniquely equipped to sense the extent of diversity in these populations1,8. In addi- marrow-derived cells and respond to tissue invasion by infectious microorgan- tion to differences in ontogeny, locally derived tissue (monocytes, macrophages and isms and tissue
    [Show full text]
  • The Systemic Inflammation of Alveolar Hypoxia Is Initiated by Alveolar
    The Systemic Inflammation of Alveolar Hypoxia Is Initiated by Alveolar Macrophage–Borne Mediator(s) Jie Chao1, John G. Wood1, Victor Gustavo Blanco1, and Norberto C. Gonzalez1 1Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas Alveolar hypoxia produces widespread systemic inflammation in rats. The inflammation appears to be triggered by activation of mast CLINICAL RELEVANCE cells by a mediator released from alveolar macrophages, not by the reduced systemic partial pressure of oxygen (PO2). If this is correct, This study demonstrates a direct link, via a circulating the following should apply: (1) neither mast cells nor tissue macro- mediator, between activation of alveolar macrophages by phages should be directly activated by hypoxia; and (2) mast cells low alveolar PO2, and degranulation of systemic mast cells, should be activated when in contact with hypoxic alveolar macro- the first step in the systemic inflammatory cascade. A phages, but not with hypoxic tissue macrophages. We sought here to candidate mediator, monocyte chemoattractant protein-1, determine whether hypoxia activates isolated alveolar macro- was identified. Roles of low tissue PO2 and activation of phages, peritoneal macrophages, and peritoneal mast cells, and to tissue macrophages were ruled out. The phenomenon study the response of the microcirculation to supernatants of these described could participate in the inflammation underlying cultures. Rat mesenteric microcirculation intravital microscopy was the systemic effects seen in conditions associated with low combined with primary cultures of alveolar macrophages, peritoneal alveolar PO2. macrophages, and peritoneal mast cells. Supernatant of hypoxic alveolar macrophages, but not of hypoxic peritoneal macrophages, produced inflammation in mesentery.
    [Show full text]
  • Letters to the Editor
    LETTERS TO THE EDITOR was discharged on long-term therapy with clar - + MonoMAC versus idiopathic CD4 lymphocytopenia . ithromycin, ethambutol, and rifampin. His skin lesions Comment to Haematologica. 2011;96(8):1221-5 resolved within a month of starting therapy. The cause of pancytopenia was initially thought to be due to BM sup - pression associated with disseminated MAC infection. We read with interest a recent article in Haematologica However, pancytopenia did not resolve and a BM biopsy describing a novel defined disorder known as MonoMAC was performed. This showed a markedly hypocellular (monocytopenia with Mycobacterium avium complex). 1 It is not infrequent for patients with MonoMAC to present with a low CD4 count, leading to a consideration of idio - pathic CD4-positive (CD4 +) lymphocytopenia (ICL). 2 Table 1. Summary of patient’s laboratory findings. Here we describe a case of MonoMAC who was initially Patient Reference range thought to have ICL and aplastic anemia. However, the combination of pancytopenia, profound monocytopenia, WBC 1.2 ¥10 9/L 4.1-10.9 ¥10 9/L and bone marrow (BM) findings support a diagnosis of Absolute neutrophil count 876 cells/ mL 1400-6500 cells/ mL MonoMAC. Absolute lymphocyte count 144 cells/ mL 1200-3400 cells/ mL A 24-year old Hispanic male presented with 2 ulcers on the lower extremities that he had had for two months. Absolute monocyte count 12 cells/ mL 300-820 cells/ mL These ulcers were 1.0 to 3.5 cm in size at their widest Hemoglobin 5.2 g/dL 14.0-18.0 g/dL point and had slightly raised erythematous borders with Hematocrit 16.2% 40-54% pink-glistening to black eschar bases (Figure 1A).
    [Show full text]
  • Regulation of Antigen-Presenting Cell Function(S) in Lung and Airway Tissues
    Eur Respir J 1993, 6, 120-129 REVIEW Regulation of antigen-presenting cell function(s) in lung and airway tissues P.G. Holt Regulation of antigen-presenting cell function(s) in lung and airway tissues. Correspondence: P.G. Holt P.G. Holt. Division of Cell Biology ABSTRACT: A variety of cell populations present in respiratory tract tissues The Western Australian Research can express the function-associated molecules on their surface which are re­ Institute for Child Health quired for presentation of antigen to T-lymphocyte receptors. However, the GPO Box 0184 Perth, Western Australia 6001. potential role of individual cell populations in regulation of local T -lymphocyte· dependent immune reactions in the lung and airways depends on a variety of Keywords: Antigen presentation additional factors, including their precise localisation, migration characteris­ airway epithelium tics, expression ofT-cell "eo-stimulatory" signals, responsiveness to inflamma­ class li MHC (I a) antigen expression tory (in particular cytokine) stimuli, host immune status, and the nature of the T-lymphocyte activation antigen challenge. Recent evidence (reviewed below) suggests that tJ1e induc­ tion of primary immunity (viz. "sensitisation") to inhaled antigens is normally Received: April 30, 1992 controlled by specialised populations of Dendritic Cells, which perform a sur­ Accepted: September 8, 1992 veillance role within the epithelia of the upper and lower respiratory tract; in the pre-sensitised host, a variety of other cell populations (both bone-marrow derived and mesenchymal) may participate in re-stimulation of "memory" T­ lymphocytes. Eur Respir J .. 1993, 6, 120-129. Aberrant immunoinflammatory responses to exog­ control of T-cell activation is normally operative to enous antigens are important aetiological factors in a protect the lung against unnecessary and/or exagger­ large proportion of the common non-malignant respi­ ated responses to foreign antigens.
    [Show full text]
  • Editorials & Perspectives
    EDITORIALS & PERSPECTIVES Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome Venetia Bigley and Matthew Collin Institute of Cellular Medicine, Newcastle University, UK. E-mail: [email protected] doi:10.3324/haematol.2011.048355 (Related Original Article on page 1221) novel immunodeficiency syndrome has recently been International Prognostic Scoring System (IPSS). defined in young adults. Known variously as dendritic It is worth emphasizing at this point that DCML deficiency cell, monocyte, B and NK lymphoid (DCML deficien - patients may have significant risk to their health before addi - A1 2 2 cy), ‘autosomal dominant and sporadic monocytopenia’ or tional cytopenias evolve. Disseminated mycobacterial infec - ‘MonoMAC’ (monocytopenia with Mycobacterium avium com - tion, PAP and carcinoma in situ may all occur prior to the onset plex), 3 it is characterized by a composite mononuclear cell defi - of an obvious myelodysplastic syndrome, underscoring the ciency, atypical mycobacterial and viral infection, and progres - fact that immunodeficiency is a cardinal feature of the disor - sion to myelodysplasia and leukemia. Strikingly, a number of der. In the series of 4 subjects described in 2011, one had mild patients also develop pulmonary alveolar proteinosis (PAP). anemia (10.3 g/dL) and one mild thrombocytopenia Patients typically present in their 3 rd or 4 th decade, although his - (123 ¥10 9/L), yet 2 required hematopoietic stem cell transplan - torical blood counts may show pre-existing monocytopenia tation (one for refractory mycobacterial infection, one for PAP) for ten years or more. A substantial number of patients devel - and a third died of influenza H1N1 prior to transplantation.
    [Show full text]
  • View Open Access Alveolar Hypoxia, Alveolar Macrophages, and Systemic Inflammation Jie Chao, John G Wood and Norberto C Gonzalez*
    Respiratory Research BioMed Central Review Open Access Alveolar hypoxia, alveolar macrophages, and systemic inflammation Jie Chao, John G Wood and Norberto C Gonzalez* Address: Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA Email: Jie Chao - [email protected]; John G Wood - [email protected]; Norberto C Gonzalez* - [email protected] * Corresponding author Published: 22 June 2009 Received: 2 April 2009 Accepted: 22 June 2009 Respiratory Research 2009, 10:54 doi:10.1186/1465-9921-10-54 This article is available from: http://respiratory-research.com/content/10/1/54 © 2009 Chao et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Diseases featuring abnormally low alveolar PO2 are frequently accompanied by systemic effects. The common presence of an underlying inflammatory component suggests that inflammation may contribute to the pathogenesis of the systemic effects of alveolar hypoxia. While the role of alveolar macrophages in the immune and defense functions of the lung has been long known, recent evidence indicates that activation of alveolar macrophages causes inflammatory disturbances in the systemic microcirculation. The purpose of this review is to describe observations in experimental animals showing that alveolar macrophages initiate a systemic inflammatory response to alveolar hypoxia. Evidence obtained in intact animals and in primary cell cultures indicate that alveolar macrophages activated by hypoxia release a mediator(s) into the circulation.
    [Show full text]
  • PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute
    Published OnlineFirst January 8, 2016; DOI: 10.1158/0008-5472.CAN-15-1566 Cancer Molecular and Cellular Pathobiology Research PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease Zejuan Li1, Ping Chen1, Rui Su2, Chao Hu1,2,3, Yuanyuan Li1, Abdel G. Elkahloun4, Zhixiang Zuo1,2, Sandeep Gurbuxani5, Stephen Arnovitz1, Hengyou Weng1,2, Yungui Wang1,2,3, Shenglai Li1, Hao Huang1, Mary Beth Neilly1, Gang Greg Wang6, Xi Jiang1,2, Paul P. Liu4, Jie Jin3, and Jianjun Chen1,2 Abstract Overexpression of HOXA/MEIS1/PBX3 homeobox genes is sion profiling of hematopoietic cells demonstrated that PBX3/ the hallmark of mixed lineage leukemia (MLL)-rearranged MEIS1 overexpression, but not HOXA9/MEIS1, HOXA9/PBX3, acute myeloid leukemia (AML). HOXA9 and MEIS1 are con- or HOXA9 overexpression, recapitulated the MLL-fusion–medi- sideredtobethemostcriticaltargetsofMLLfusionsandtheir ated core transcriptome, particularly upregulation of the endog- coexpression rapidly induces AML. MEIS1 and PBX3 are not enous Hoxa genes. Disruption of the binding between MEIS1 individually able to transform cells and were therefore hypoth- andPBX3diminishedPBX3/MEIS1–mediated cell transforma- esized to function as cofactors of HOXA9. However, in this tion and HOX gene upregulation. Collectively, our studies study, we demonstrate that coexpression of PBX3 and MEIS1 strongly implicate the PBX3/MEIS1 interaction as a driver of (PBX3/MEIS1), without ectopic expression of a HOX gene, is cell transformation and leukemogenesis, and suggest that this sufficient for transformation of normal mouse hematopoietic axis may play a critical role in the regulation of the core stem/progenitor cells in vitro.Moreover,PBX3/MEIS1 overex- transcriptional programs activated in MLL-rearranged and pression also caused AML in vivo, with a leukemic latency HOX-overexpressing AML.
    [Show full text]
  • Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps
    biomolecules Review Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps Brandon Bautista-Becerril 1,2,†, Rebeca Campi-Caballero 2,3,†, Samuel Sevilla-Fuentes 4, Laura M. Hernández-Regino 5, Alejandro Hanono 6 , Al Flores-Bustamante 7, Julieta González-Flores 2 , Carlos A. García-Ávila 5 , Arnoldo Aquino-Gálvez 8 , Manuel Castillejos-López 9 , Armida Juárez-Cisneros 1 and Angel Camarena 1,* 1 Laboratorio HLA, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico; [email protected] (B.B.-B.); [email protected] (A.J.-C.) 2 Programa MEDICI, Carrera Médico Cirujano, FES Iztacala, Universidad Nacional Autónoma de México, Mexico City 54090, Mexico; [email protected] (R.C.-C.); [email protected] (J.G.-F.) 3 Laboratorio de Neuropsicofarmacología, Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico 4 Departamento de Infectología, Hospital General de México Eduardo Liceaga, Mexico City 06720, Mexico; [email protected] 5 Escuela Nacional de Ciencias Biológicas, Programa de Posgrado, Instituto Politécnico Nacional, Mexico City 11340, Mexico; [email protected] (L.M.H.-R.); [email protected] (C.A.G.-Á.) Citation: Bautista-Becerril, B.; 6 Facultad de Ciencias de la Salud, Universidad Anáhuac México Norte, Mexico City 52786, Mexico; Campi-Caballero, R.; Sevilla-Fuentes, [email protected] S.; Hernández-Regino, L.M.; Hanono, 7 Laboratorio de Farmacología, Instituto
    [Show full text]
  • Secondary Pulmonary Alveolar Proteinosis in Hematologic
    review Secondary pulmonary alveolar proteinosis in hematologic malignancies Chakra P Chaulagain a,*, Monika Pilichowska b, Laurence Brinckerhoff c, Maher Tabba d, John K Erban e a Taussig Cancer Institute of Cleveland Clinic, Department of Hematology/Oncology, Cleveland Clinic in Weston, FL, USA, b Department of Pathology, Tufts Medical Center Cancer Center & Tufts University School of Medicine, Boston, MA, USA, c Department of Surgery, Tufts Medical Center Cancer Center & Tufts University School of Medicine, Boston, MA, USA, d Division of Critical Care, Pulmonary and Sleep Medicine, Tufts Medical Center Cancer Center & Tufts University School of Medicine, Boston, MA, USA, e Division of Hematology/Oncology, Tufts Medical Center Cancer Center & Tufts University School of Medicine, Boston, MA, USA * Corresponding author at: Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd., Weston, FL 33331, USA. Tel.: +1 954 659 5840; fax: +1 954 659 5810. Æ [email protected] Æ Received for publication 29 January 2014 Æ Accepted for publication 1 September 2014 Hematol Oncol Stem Cell Ther 2014; 7(4): 127–135 ª 2014 King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. All rights reserved. DOI: http://dx.doi.org/10.1016/j.hemonc.2014.09.003 Abstract Pulmonary alveolar proteinosis (PAP), characterized by deposition of intra-alveolar PAS positive protein and lipid rich material, is a rare cause of progressive respiratory failure first described by Rosen et al. in 1958. The intra-alveolar lipoproteinaceous material was subsequently proven to have been derived from pulmonary surfactant in 1980 by Singh et al. Levinson et al. also reported in 1958 the case of 19- year-old female with panmyelosis afflicted with a diffuse pulmonary disease characterized by filling of the alveoli with amorphous material described as ‘‘intra-alveolar coagulum’’.
    [Show full text]
  • Differential Role of Neutrophils and Alveolar Macrophages In
    0023-6837/02/8208-1015$03.00/0 LABORATORY INVESTIGATION Vol. 82, No. 8, p. 1015, 2002 Copyright © 2002 by The United States and Canadian Academy of Pathology, Inc. Printed in U.S.A. Differential Role of Neutrophils and Alveolar Macrophages in Hepatocyte Growth Factor Production in Pulmonary Fibrosis Bruno Crestani, Monique Dehoux, Gilles Hayem, Véronique Leçon, Francine Hochedez, Joëlle Marchal, Sandrine Jaffré, Jean-Baptiste Stern, Geneviève Durand, Dominique Valeyre, Michel Fournier, and Michel Aubier INSERM Unit 408 (BC, MD, JM, SJ, J-BS, MF, MA), Faculté Xavier Bichat, and Laboratoire de Biochimie A (MD, VL, FH, GD), Service de Pneumologie (BC, MA), and Service de Rhumatologie (GH), Hôpital Bichat, Paris, and Service de Pneumologie (MF), Hôpital Beaujon, Clichy, and Service de Pneumologie (DV), Hôpital Avicenne, Bobigny, Assistance Publique-Hôpitaux de Paris, France SUMMARY: Neutrophils may participate in the development of lung fibrosis. Hepatocyte growth factor (HGF), a growth factor for type II pneumocytes, is produced by neutrophils. We measured the production of HGF by blood and alveolar neutrophils from patients with either idiopathic pulmonary fibrosis (n ϭ 11) or connective tissue disease-associated pulmonary fibrosis (n ϭ 10) and from control patients (n ϭ 10). HGF secretion by alveolar macrophages and the expression of the HGF receptor by alveolar epithelial cells in pulmonary fibrosis were also evaluated. HGF was not detected in bronchoalveolar lavage fluid from controls. HGF concentration in the epithelial lining fluid from patients was 4-fold higher than in plasma, suggesting a local production within the alveolar space. Alveolar neutrophils secreted HGF in vitro. Basal HGF secretion by alveolar neutrophils positively correlated with HGF in the epithelial lining fluid (p ϭ 0.05, rho ϭ 0.582).
    [Show full text]